Vanda Pharmaceuticals Gross Loans (Quarterly) Insights

Vanda Pharmaceuticals, Inc. (VNDA)

8.15 +2.39 (+41.49%) USD | NASDAQ | Feb 23, 16:00

8.07 -0.08 (-0.98%) Pre-Market: 08:25

View Gross Loans (Quarterly) for VNDA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Gross Loans (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Gross Loans (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Gross Loans (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	--
Axsome Therapeutics, Inc.	--
AnaptysBio, Inc.	--
SELLAS Life Sciences Group, Inc.	--
Protagenic Therapeutics, Inc.	--